The FDA has approved obinutuzumab for the treatment of adults with active lupus nephritis who are receiving standard therapy, ...
GLP-1 receptor agonists and fenofibrate medications significantly reduced the risk for developing diabetic macular edema, ...
Music with more predictability was shown to “entrain” listeners’ blood pressure, suggesting music-based BP modulation ...
Seed oils, though often found in unhealthy foods, serve an important role in a healthy diet by functioning as a “key source” ...
Adults with type 1 diabetes using one of three GLP-1-based medications had significantly greater reductions in body weight ...
With regard to respiratory tuberculosis-related deaths from 1999 to 2020, common populations included older adults, males and ...
Epioxa is the first epithelium-on cross-linking procedure approved in the U.S. Glaukos plans for Epioxa to be commercially ...
The FDA has accepted Pharming Group’s supplemental new drug application for leniolisib in treating activated phosphoinositide ...
Patients with lupus nephritis who received hydroxychloroquine demonstrated a significantly lower risk for glomerular ...
The FDA approved expanded indications of Yuflyma and its unbranded version to treat hidradenitis suppurativa in adolescents aged 12 years and older and uveitis in children aged 2 years and older, ...
Drugs commonly used in cancer immunotherapy carry the risk for ocular adverse events, according to a speaker.In a ...
Across several clinical outcomes, including 28-day mortality, beta-blocker esmolol was more effective than standard care and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback